Cancer Genetics Shares Rally As Feltl Analyst Getting More Bullish
October 02, 2013 at 11:01 AM EDT
Shares of Cancer Genetics (NASDAQ: CGIX ) are on the move Wednesday morning following some positive comments and a raised price target from Feltl & Co.'s Ben Haynor. The analyst now sees Cancer Genetics shares rising to $30.50 over the next year, up from $17.50 previously. The Feltl analyst cited
